Oracle buys medical records company Cerner for $28 billion

By AP News

Share:

In this article

  • Loading...
  • Want to see what you should be buying? Check out our top picks.

Software maker Oracle is buying electronic medical records company Cerner in an all-cash deal valued at about $28.3 billion.

In this March 22, 2011 photo, the company logo for Oracle Corp. headquarters is shown in Redwood City, Calif. Oracle is buying electronic medical records company Cerner. The companies said Monday, Dec. 20, 2021 that Cerner systems running on the Oracle Gen2 Cloud will be available 24 hours a day, every day, with the goal of having zero unplanned downtime. (AP Photo/Paul Sakuma, file)

Software maker Oracle is buying electronic medical records company Cerner in an all-cash deal valued at about $28.3 billion.

Oracle will pay $95 per Cerner share and the deal is expected to close next year.

Hospitals and physicians offices use Cerner software to record and share health and medical data. The companies said Monday that Cerner systems running on the Oracle Gen2 Cloud will be available 24 hours a day, every day, with the goal of having zero unplanned downtime.

Cerner, based in Kansas City, Missouri, will become a unit of Oracle.

Shares of Oracle Corp., which is based in Austin, Texas, fell more than 2.8% in morning trading.

Share:

In this article:

Industries:
Financials
Information Technology
Companies:
Oracle

Author: AP News

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Originally published by Associated Press Valuethemarkets.com, Digitonic Ltd (and our owners, directors, officers, managers, employees, affiliates, agents and assigns) are not responsible for the content or accuracy of this article. The information included in this article is based solely on information provided by the company or companies mentioned above.

Sign up for Investing Intel Newsletter